Skip to content
Catalyst

magnesium(2+)Finding

Magnesium(2+) decreases postoperative atrial fibrillation incidence

lowersModerate evidenceFindingreplicated ×3

01 · The sentence it was drawn from

“The pooled analysis showed that intravenous magnesium significantly reduced the incidence of POAF by 36% (RR 0.64; 95% CI 0.50-0.83; P = 0.001; Figure 2), with no heterogeneity between trials (heterogeneity P = 0.8; I2 = 0%).”
Quoted verbatim from Intravenous magnesium prevents atrial fibrillation after coronary artery bypass grafting: a meta-analysis of 7 double-blind, placebo-controlled, randomized clinical trials.
This finding among the 7 findings on its endpoint

magnesium(2+)

Postoperative atrial fibrillation incidence

lowers

Effect as reported

0.64risk ratio

CI 0.5 to 0.83

Who
Adults undergoing coronary artery bypass grafting; pooled seven double-blind placebo-controlled randomized trials (placebo dextrose or saline infusion)
Dose studied
intravenous magnesium, total dose ranging from 8 to 100 mmol across trials (one trial not available)

Moderate evidencePMID 22520937 · 2012

02 · The study

Study
meta-analysis
Duration
not reported

Evidence, by strength

  • strong
  • moderatethis finding
  • limited
  • very limited
  • insufficient

03 · The paper

Trials
What else it reported1 finding · 1 compound · 1 endpoint

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M6Y40BP4SJBP3HVNNCY81G6F